Table 1– Inhaled respiratory therapy in 421 chronic obstructive pulmonary disease patients according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 classification

	GOLD category
	Total^#	A^¶	B⁺	C^§				D^ƒ
	Total^#			Total	C1^##	C2^¶¶	C3⁺⁺	Total	D1^§§	D2^ƒƒ	D3^###
Any ICS	253 (60)	44 (42)^¶¶¶,+++	28 (50)^¶¶¶,+++	69 (59)	26 (54)^¶¶¶	25 (61)^¶¶¶,+++	18 (67)	112 (78)	36 (68)^¶¶¶	19 (68)^¶¶¶	57 (90)
Any LABA	283 (67)	47 (45)	37 (66)	80 (69)	27 (56)	31 (76)	22 (81)	119 (83)	39 (74)	21 (75)	59 (94)
Any LAMA	223 (53)	50 (48)	34 (61)	50 (43)	27 (56)	10 (24)	13 (48)	89 (62)	28 (53)	17 (61)	44 (70)
ICS alone	9 (2)^¶¶¶,+++	2 (2)^¶¶¶,+++	2 (4)^¶¶¶,+++	0	0	0	0	5 (3)^¶¶¶,+++	1 (2)^¶¶¶,+++	1 (4)^¶¶¶,+++	3 (4)^¶¶¶,+++
ICS/LABA	99 (24)	17 (16)^¶¶¶,+++	8 (14)^¶¶¶,+++	39 (34)	9 (19)	22 (54)^¶¶¶	8 (30)	35 (24)	14 (26)^¶¶¶	5 (18)^¶¶¶	16 (25)
ICS/LAMA	8 (2)^¶¶¶,+++	4 (4)^¶¶¶,+++	0	1 (1)^¶¶¶,+++	1 (2)^¶¶¶,+++	0	0	3 (3)^¶¶¶,+++	2 (4)^¶¶¶,+++	1 (4)^¶¶¶,+++	0
ICS/LABA/LAMA	137 (33)	21 (20)	18 (32)^¶¶¶,+++	29 (25)	16 (33)^¶¶¶	3 (7)^¶¶¶	10 (37)	69 (48)	19 (36)	12 (43)	38 (60)
LABA/LAMA	28 (7)	4 (4)	8 (14)	6 (5)	1 (2)	3 (7)	2 (7)	10 (7)	3 (6)	2 (7)	5 (8)

Data are presented as n (%). ICS: inhaled corticosteroid; LABA: long-acting β₂-agonist; LAMA: long-acting muscarinic antagonist. ^#: n=421; ^¶: modified Medical Research Council (mMRC) dyspnoea score <2, forced expiratory volume in 1 s (FEV₁) ≥50% predicted and fewer than two exacerbations per year, n=105 (25%); ⁺: mMRC dyspnoea score ≥2, FEV₁ ≥50% pred and fewer than two exacerbations per year, n=56 (13%); ^§: mMRC dyspnoea score <2, FEV₁ <50% pred or two or more exacerbations per year, n=116 (28%); ^ƒ: mMRC dyspnoea score ≥2, FEV₁ <50% pred or two or more exacerbations per year, n=144 (43%); ^##: FEV₁ <50% pred, n=48; ^¶¶: two or more exacerbations per year, n=41; ⁺⁺: both FEV₁ <50% pred and two or more exacerbations per year, n=27; ^§§: FEV₁ <50% pred, n=53; ^ƒƒ: more than two exacerbations per year, n=28; ^###: both FEV₁ <50% pred and two or more exacerbations per year, n=63; ^¶¶¶: inappropriate prescription according to GOLD 2007; ⁺⁺⁺: inappropriate prescription according to GOLD 2011.